BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28041834)

  • 1. The HLA-G 14-base pair deletion allele and the deletion/deletion genotype are associated with persistent HBe antigenemia in chronic hepatis B infection.
    Ferreira SD; Chachá SG; Souza FF; Teixeira AC; Santana RC; Deghaide NH; Rodrigues S; Marano LA; Mendes-Junior CT; Ramalho LN; Zucoloto S; Donadi EA; Martinelli AL
    Hum Immunol; 2017 Feb; 78(2):166-171. PubMed ID: 28041834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.
    Laaribi AB; Zidi I; Hannachi N; Ben Yahia H; Chaouch H; Bortolotti D; Zidi N; Letaief A; Yacoub S; Boudabous A; Rizzo R; Boukadida J
    J Viral Hepat; 2015 Oct; 22(10):835-41. PubMed ID: 25619305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HLA-G 14-bp insertion/deletion polymorphism is associated with chronic hepatitis B in Southern Brazil: A case-control study.
    Michel Wolf J; Zingalli Bueno Pereira VR; Zanetti Ballardin Roncato PA; Castagna Wortmann A; Stumm GZ; Oliveira da Silva F; Lunge VR; Simon D
    Hum Immunol; 2020; 81(2-3):79-84. PubMed ID: 31955869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection.
    Kim SK; Chung JH; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI; Shin HP
    Hepatogastroenterology; 2013 Jun; 60(124):796-8. PubMed ID: 23732778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G gene 14-bp deletion variant protects Iranian subjects against chronic hepatitis B infection.
    Eskandari E; Dahmardeh T; Safdari V; Khosravi S; Pahlevani E
    Int J Immunogenet; 2017 Dec; 44(6):322-327. PubMed ID: 28929613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus infection in an Iranian cohort.
    Moudi B; Heidari Z; Mahmoudzadeh-Sagheb H; Hashemi M
    Microbiol Immunol; 2016 Jun; 60(6):390-6. PubMed ID: 27079941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection.
    Lam YF; Wong DK; Seto WK; To KK; Hung IF; Fung J; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2014 Mar; 29(3):533-9. PubMed ID: 23980639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
    Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
    Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
    J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
    Rodriguez-Frias F; Jardi R; Buti M; Schaper M; Hermosilla E; Valdes A; Allende H; Martell M; Esteban R; Guardia J
    J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM; Chen YC; Tai DI; Liaw YF
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroconversion during antiviral treatment.
    Hao R; Xiang K; Peng Y; Hou J; Sun J; Li Y; Su M; Yan L; Zhuang H; Li T
    Infect Genet Evol; 2015 Jul; 33():261-8. PubMed ID: 25976382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
    Atay AE; Seven G; Yalcin K; Pasa S; Degertekin H
    J Int Med Res; 2012; 40(5):1891-6. PubMed ID: 23206472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
    Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
    J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.